🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14,283 results for “B” Clear

  1. Subutex 300 mg injektionsvätska, depotlösning, Subutex 100 mg injektionsvätska, depotlösning

    Indivior Pty Ltd

    Opioid Use Disorder

    approved small molecule active

    1 trial

  2. Succinylcholine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    the Effect of Succinylcholine on Barrier Pressure

    approved small molecule completed

    1 trial

  3. Sugammadex hameln 100 mg/ml oplossing voor injectie, Naloxon HCl Accord 0,4 mg/ml, oplossing voor injectie / infusie in een voorgevulde spuit, ANEXATE 0,5 mg/5 ml, solution injectable (I.V.), REMIMAZOLAM , Sufentanil Viatris 5 microgram/ml oplossing voor injectie, Esmeron 10 mg/ml, oplossing voor injectie

    Disc Medicine

    General anesthesia

    approved small molecule active

    1 trial

  4. Sulfato de Magnesio Altan 150 mg/ml solución inyectable y para perfusión EFG, LIDOCAINE HYDROCHLORIDE, Dexdor 100 micrograms/ml concentrate for solution for infusion, KETOLAR 50 mg/ml solución inyectable.

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  5. Surabgene Lomparvovec (ABBV-RGX-314), Lucentis 10 mg/ml solution for injection in pre-filled syringe, Surabgene Lomparvovec (ABBV-RGX-314)

    AbbVie Deutschland GmbH & Co. KG

    Neovascular age-related macular degeneration

    approved small molecule active

    1 trial

  6. Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

    GT Biopharma

    Glioblastoma

    approved other active

    1 trial

  7. Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg

    AstraZeneca

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule completed

    1 trial

  8. Symbicort Turbuhaler 160/4.5

    AstraZeneca

    Asthma

    approved small molecule completed

    1 trial

  9. T-jet® containing TevTropin®

    Teva Pharma GmbH

    Growth Hormone Deficiency

    approved other completed

    1 trial

  10. TACROLIMUS, SIROLIMUS, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, PREDNISOLONE, EVEROLIMUS, MYCOPHENOLIC ACID, BELATACEPT, CICLOSPORIN

    The George Institute

    BK Polyomavirus DNAemia after kidney transplantation

    approved small molecule active

    1 trial

  11. TAGRISSO 80 mg film-coated tablets

    Disc Medicine

    EGFR mutated locally advanced or metastatic non-small cell lung cancer

    approved small molecule active

    1 trial

  12. TAGRISSO 80 mg film-coated tablets

    Fondazione Telethon ETS

    Patients with EGFR mutant NSCLC according to TP53 mutational status

    approved small molecule active

    1 trial

  13. TAGRISSO 80 mg film-coated tablets

    Disc Medicine

    EGFR mutated locally advanced or metastatic non-small cell lung cancer

    approved small molecule active

    1 trial

  14. TAMOXIFEN

    Disc Medicine

    Breast cancer

    approved small molecule active

    1 trial

  15. TDF

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    approved small molecule completed

    1 trial

  16. TESTOGEL 50 mg gel transdérmico en sobres, Decapeptyl diario 0,1 mg polvo y disolvente para solución inyectable, Bemfola 300 IU/0.50 mL solution for injection in pre-filled pen, Astarté 0,25 mg/0,5 ml solución inyectable en jeringa precargada EFG

    The George Institute

    low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

    approved small molecule active

    1 trial

  17. TIMOFEROL 50 mg, comprimé enrobé, TIMOFEROL, gélule, FERRIC CARBOXYMALTOSE

    Pari Pharma GmbH

    Women who delivered by caesarean and have a moderate postpartum iron deficiency anaemia defined by 8.0 g/dL ≤ postoperative Hb level ≤ 10.0 g/dL within 72h after delivery and a ferritinemia ≤ 100 ng/mL OR transferrin saturation ≤ 20% (Measured after postoperative Hb level measurement)

    approved small molecule active

    1 trial

  18. TM buprenorphine

    Indivior Pty Ltd

    Opioid-use Disorder

    approved small molecule completed

    1 trial

  19. TMT212, TMT212, Mekinist 0.5 mg film-coated tablets, Mekinist 2 mg film-coated tablets, DRB436, DRB436, DRB436, TMT212

    Novartis Pharmaceuticals

    Multiple indications

    approved small molecule active

    1 trial

  20. TPO-RAs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenia (ITP)

    approved small molecule active

    1 trial

  21. TRALOKINUMAB, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP.

    LEO Pharma A/S

    Atopic dermatitis and moderate-to severe atopic hand eczema

    approved small molecule active

    1 trial

  22. TYRX™ Absorbable Antibacterial Envelope

    Rhythm Pharmaceuticals Netherlands B.V.

    CIED Related Infection

    approved other completed

    1 trial

  23. Talzenna 1 mg hard capsules

    Disc Medicine

    Breast cancer

    approved small molecule active

    1 trial

  24. Taneasy 600mg granules

    Biotech Pharmaceutical Co.,

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources